Medifast, Inc. Earnings Recaps
Q3 2025
Nov 4, 2025
Medifast's third-quarter results for 2025 showcased a strategic shift towards a holistic approach to metabolic health, reinforcing its commitment to long-term wellness solutions while navigating changes in the weight loss industry.
Key takeaways
- Achieved 16-week clinical results showing clients retained 98% of lean mass and reduced visceral fat by 14%, underscoring the effectiveness of its metabolic health programs.
- Expanded insights with 61% of coaches assisting clients using GLP-1 medications, highlighting the integration of medication knowledge into client support.
- Announced plans for innovative product launches incorporating next-generation ingredients targeting metabolic enhancement, set to hit the market next year.
- Transitioning brand perception from a weight loss company to a broader leader in metabolic health, targeting a more expansive and durable market.